Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC A-674563 hydrochloride | 2070009-66-2 | 99.9% | C22H23ClN4O | 10MG
SDP

Catalog No. 5000261160
Encompass_Preferred

A-674563 hydrochloride is a potent, selective Akt1 (protein kinase B) inhibitor with a reported Ki of 11 nM. It shows in vitro anti-proliferative and pro-apoptotic activity across multiple cancer cell lines and has been used in vivo to investigate Akt-dependent signaling and combination therapies.

  • Potent Akt1 inhibition (Ki ≈11 nM).
  • High purity suitable for research use (≈99.9%).
  • Demonstrated antiproliferative activity in tumor cell assays (EC50 ≈0.4 μM).
  • Effective in in vivo models for studying Akt signaling and combination regimens.
  • Available as solid and DMSO solution formats for flexible dosing.

Catalog No. 50-002-61160 Supplier Medchemexpress LLC Supplier No. HY13254A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

A-674563 hydrochloride is a potent, selective Akt1 (protein kinase B) inhibitor with a reported Ki of 11 nM. It shows in vitro anti-proliferative and pro-apoptotic activity across multiple cancer cell lines and has been used in vivo to investigate Akt-dependent signaling and combination therapies.

  • Potent Akt1 inhibition (Ki ≈11 nM).
  • High purity suitable for research use (≈99.9%).
  • Demonstrated antiproliferative activity in tumor cell assays (EC50 ≈0.4 μM).
  • Effective in in vivo models for studying Akt signaling and combination regimens.
  • Available as solid and DMSO solution formats for flexible dosing.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.